BMS-201038 (AEGR-733)

AEGR-733 · Aegerion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-201038 (AEGR-733), covering 2014-03-04 to 2014-03-04. Get the full timeline:

Most recent: Clinical Trial Update: The Safety & Efficacy of Combination BMS-201038 (AEGR-733) & Ezetimibe vs. Monotherapy in Moderate Hypercholesterolemia [Phase 2]

See pricing